Literature DB >> 3259036

Treatment of patients with advanced cancer using tumor-infiltrating lymphocytes and interleukin 2.

R Kradin1, S Dubinett, J Mullin, L Boyle, H W Strauss, P M Bourgoin, F I Preffer, J Kurnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3259036

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  IL-2 and Beyond in Cancer Immunotherapy.

Authors:  John M Wrangle; Alicia Patterson; C Bryce Johnson; Daniel J Neitzke; Shikhar Mehrotra; Chadrick E Denlinger; Chrystal M Paulos; Zihai Li; David J Cole; Mark P Rubinstein
Journal:  J Interferon Cytokine Res       Date:  2018-02       Impact factor: 2.607

2.  GD3-reactive antibodies can inhibit the lysis of autologous tumor cells by tumor-infiltrating lymphocytes.

Authors:  E B Reilly; G Antognetti
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Adoptive immunotherapy with interleukin-2 (IL-2) results in diminished IL-2 production by stimulated peripheral blood lymphocytes.

Authors:  R Kradin; J Kurnick; J Gifford; C Pinto; F Preffer; D Lazarus
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

4.  Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.

Authors:  A Gorter; K M Krüse; P I Schrier; G J Fleuren; R J van de Griend
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

5.  Intratumoral interleukin-2 immunotherapy: activation of tumor-infiltrating and splenic lymphocytes in vivo.

Authors:  S M Dubinett; L Patrone; J Tobias; A J Cochran; D R Wen; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 6.  Evolving Immunotherapy Approaches for Renal Cell Carcinoma.

Authors:  Susanna A Curtis; Justine V Cohen; Harriet M Kluger
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.945
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.